| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England journal of medicine 383 (6), 517-525, 2020 | 1592 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 653 | 2020 |
| Emerging fungal infections: new patients, new patterns, and new pathogens DZP Friedman, IS Schwartz Journal of Fungi 5 (3), 67, 2019 | 306 | 2019 |
| Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open forum infectious diseases 7 (4), ofaa130, 2020 | 245 | 2020 |
| Re-drawing the maps for endemic mycoses N Ashraf, RC Kubat, V Poplin, AA Adenis, DW Denning, L Wright, ... Mycopathologia 185, 843-865, 2020 | 220 | 2020 |
| Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International … GR Thompson, T Le, A Chindamporn, CA Kauffman, ... The Lancet Infectious Diseases 21 (12), e364-e374, 2021 | 141 | 2021 |
| Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales) K Dukik, JF Muñoz, Y Jiang, P Feng, L Sigler, JB Stielow, J Freeke, ... Mycoses 60 (5), 296-309, 2017 | 137 | 2017 |
| Coronavirus disease 2019–associated invasive fungal infection JW Baddley, GR Thompson III, SCA Chen, PL White, MD Johnson, ... Open forum infectious diseases 8 (12), ofab510, 2021 | 108 | 2021 |
| High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada IS Schwartz, DZP Friedman, L Zapernick, TC Dingle, N Lee, W Sligl, ... Clinical Infectious Diseases 71 (7), 1760-1763, 2020 | 99 | 2020 |
| Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies CJ Clancy, IS Schwartz, B Kula, MH Nguyen Open Forum Infectious Diseases 8 (3), ofab065, 2021 | 86 | 2021 |
| Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis Y Jiang, K Dukik, JF Munoz, L Sigler, IS Schwartz, NP Govender, ... Fungal Diversity 90, 245-291, 2018 | 84 | 2018 |
| Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series IS Schwartz, NP Govender, C Corcoran, S Dlamini, H Prozesky, R Burton, ... Clinical Infectious Diseases 61 (6), 1004-1012, 2015 | 84 | 2015 |
| Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States IS Schwartz, NP Wiederhold, KE Hanson, TF Patterson, L Sigler Clinical Infectious Diseases 68 (2), 188-195, 2019 | 83 | 2019 |
| Invasive mould disease in fatal COVID-19: a systematic review of autopsies BE Kula, CJ Clancy, MH Nguyen, IS Schwartz The Lancet Microbe 2 (8), e405-e414, 2021 | 78 | 2021 |
| 50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens IS Schwartz, C Kenyon, P Feng, NP Govender, K Dukik, L Sigler, Y Jiang, ... PLoS pathogens 11 (11), e1005198, 2015 | 77 | 2015 |
| Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae CR Kenyon, IS Schwartz Emerging Infectious Diseases 24 (7), 1195, 2018 | 76 | 2018 |
| Outbreak Detection: First reported case of multidrug-resistant Candida auris in Canada IS Schwartz, GW Hammond Canada Communicable Disease Report 43 (7-8), 150, 2017 | 74 | 2017 |
| Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis RM Kariyawasam, TC Dingle, BE Kula, B Vandermeer, WI Sligl, ... Clinical Microbiology and Infection 28 (7), 920-927, 2022 | 65 | 2022 |
| Emergomyces: The global rise of new dimorphic fungal pathogens IS Schwartz, NP Govender, L Sigler, Y Jiang, TG Maphanga, B Toplis, ... PLoS Pathogens 15 (9), e1007977, 2019 | 64 | 2019 |
| Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19 SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ... Open forum infectious diseases 7 (11), ofaa500, 2020 | 60 | 2020 |
Chris KenyonInstitute of Tropical Medicine, Antwerp在 itg.be 的电子邮件经过验证
Chris KenyonInstitute of Tropical Medicine, Antwerp在 itg.be 的电子邮件经过验证
Lynne SiglerUniversity of Alberta, Edmonton, Canada在 ualberta.ca 的电子邮件经过验证